
Designer Baby Companies Are in Turmoil
Bootstrap Bio and Manhattan Genomics, which were pursuing gene editing in human embryos to prevent serious disease, have shut down.
ScienceApr 25, 2026, 2:09 PMStaff Reporter

Image: Science

Bootstrap Bio and Manhattan Genomics, which were pursuing gene editing in human embryos to prevent serious disease, have shut down.